全文获取类型
收费全文 | 932301篇 |
免费 | 51845篇 |
国内免费 | 1416篇 |
专业分类
耳鼻咽喉 | 10771篇 |
儿科学 | 31162篇 |
妇产科学 | 21659篇 |
基础医学 | 135401篇 |
口腔科学 | 22344篇 |
临床医学 | 80483篇 |
内科学 | 175139篇 |
皮肤病学 | 17663篇 |
神经病学 | 70297篇 |
特种医学 | 36321篇 |
外国民族医学 | 76篇 |
外科学 | 141389篇 |
综合类 | 17727篇 |
现状与发展 | 2篇 |
一般理论 | 188篇 |
预防医学 | 73699篇 |
眼科学 | 19729篇 |
药学 | 65985篇 |
3篇 | |
中国医学 | 3051篇 |
肿瘤学 | 62473篇 |
出版年
2021年 | 6253篇 |
2019年 | 6223篇 |
2018年 | 31712篇 |
2017年 | 25195篇 |
2016年 | 29265篇 |
2015年 | 9387篇 |
2014年 | 12203篇 |
2013年 | 17754篇 |
2012年 | 29737篇 |
2011年 | 45525篇 |
2010年 | 33200篇 |
2009年 | 25308篇 |
2008年 | 43339篇 |
2007年 | 48323篇 |
2006年 | 24198篇 |
2005年 | 24802篇 |
2004年 | 25866篇 |
2003年 | 26645篇 |
2002年 | 23620篇 |
2001年 | 37198篇 |
2000年 | 38105篇 |
1999年 | 31083篇 |
1998年 | 8476篇 |
1997年 | 7287篇 |
1996年 | 7356篇 |
1995年 | 7034篇 |
1994年 | 6501篇 |
1993年 | 5936篇 |
1992年 | 23423篇 |
1991年 | 23446篇 |
1990年 | 22797篇 |
1989年 | 22478篇 |
1988年 | 20387篇 |
1987年 | 19817篇 |
1986年 | 18842篇 |
1985年 | 17647篇 |
1984年 | 13015篇 |
1983年 | 11023篇 |
1982年 | 6182篇 |
1979年 | 11774篇 |
1978年 | 8317篇 |
1977年 | 6950篇 |
1976年 | 6753篇 |
1975年 | 7366篇 |
1974年 | 8643篇 |
1973年 | 8247篇 |
1972年 | 7729篇 |
1971年 | 7200篇 |
1970年 | 6989篇 |
1969年 | 6401篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
62.
63.
64.
N. V. Bashmakova G. N. Chistiakova I. A. Gazieva Y. M. Trapeznikova D. O. Mazurov 《Gynecological endocrinology》2015,31(10):31-33
AbstractThis study was undertaken to compare the concentrations of pro- and anti-angiogenic growth factors, nitric oxide (NO) stable metabolites in maternal serum and embryonic left ventricular (LV) isovolumic relaxation time (IRT, ms) during the first trimester in two groups of women: with pregnancy conceived by assisted reproductive technologies (ART, n?=?39) and normally conceived (control group, n?=?68) pregnancy. The concentration of vasoconstrictor endothelin 1 was 45.5 times more in ART than in control group. On the contrary, the concentrations of NO stable metabolites in ART were 1.9 times less than in control women. The assessment of angiogenic suppressors in ART women demonstrates the decrease in s-endoglin concentration was 1.6 times and in soluble receptor to vascular endothelial growth factor concentration was 2.0 times in comparison with control group. There was a significant increase in LV IRT in ART embryos in comparison to control ones. These data suggest significant changes in pro- anti-angiogenic factors balance and increase in vascular impedance in ART-conceived embryos. 相似文献
65.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516
66.
67.
Letter: faecal volatile organic metabolites,promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply 下载免费PDF全文
I. Ahmed R. Greenwood B. Costello N. Ratcliffe C. Probert 《Alimentary pharmacology & therapeutics》2016,43(11):1241-1242
68.
69.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.70.
Gregory N. Gan 《Expert opinion on investigational drugs》2016,25(10):1153-1166
Introduction: Cancer treatment is moving away from conventional cytotoxic drugs and towards agents that target specific proteins and mechanisms important to cancer development or survival. The Hedgehog Pathway (HhP) is a signal transduction pathway and its constitutive activation is tumorigenic in basal cell carcinoma (BCC). The HhP enables phenotypic flexibility, and channels tumor-stroma interactions. As a result, it is over-expressed in numerous cancers as well as in the tumor microenvironment and may represent a promising therapeutic target.Areas covered: In this article, we review the rationale for targeting HhP and its role as an oncogenic driver, in tumor epithelial-to-mesenchymal transition (EMT), and in the tumor microenvironment and describe the results of preclinical and clinical studies involving HhP inhibitors.Expert opinion: HhP activation plays an important role in both the tumor microenvironment and tumor EMT which can lead to treatment resistance for a number of different malignancies. In addition to standard use in BCC, several HhP inhibitors are in preclinical, early, and mid-stage clinical development for other solid and hematologic malignancies. 相似文献